TRA Relative Valuation - Traphaco JSC - Alpha Spread
T

Traphaco JSC
VN:TRA

Watchlist Manager
Traphaco JSC
VN:TRA
Watchlist
Price: 77 500 VND Market Closed
Market Cap: 3.2T VND
Have any thoughts about
Traphaco JSC?
Write Note

Relative Value

The Relative Value of one TRA stock under the Base Case scenario is 78 162.8 VND. Compared to the current market price of 77 500 VND, Traphaco JSC is Undervalued by 1%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TRA Relative Value
Base Case
78 162.8 VND
Undervaluation 1%
Relative Value
Price
T
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
60
vs Industry
61
Median 3Y
1.4
Median 5Y
1.4
Industry
2.6
Forward
1.2
vs History
60
vs Industry
29
Median 3Y
15.5
Median 5Y
15.5
Industry
22.9
Forward
11.2
vs History
60
vs Industry
22
Median 3Y
16.7
Median 5Y
16.7
Industry
17.6
vs History
60
vs Industry
24
Median 3Y
50
Median 5Y
50
Industry
25.2
vs History
60
vs Industry
33
Median 3Y
2.3
Median 5Y
2.3
Industry
2.2
vs History
60
vs Industry
65
Median 3Y
1.2
Median 5Y
1.2
Industry
2.7
Forward
1
vs History
60
vs Industry
67
Median 3Y
2.3
Median 5Y
2.3
Industry
5.4
vs History
60
vs Industry
41
Median 3Y
6.9
Median 5Y
6.9
Industry
13.9
Forward
5.2
vs History
60
vs Industry
38
Median 3Y
8.9
Median 5Y
8.9
Industry
17.3
Forward
6.5
vs History
60
vs Industry
25
Median 3Y
14.1
Median 5Y
14.1
Industry
16.1
vs History
60
vs Industry
12
Median 3Y
29.5
Median 5Y
29.5
Industry
18.8
vs History
60
vs Industry
34
Median 3Y
2.2
Median 5Y
2.2
Industry
2

Multiples Across Competitors

TRA Competitors Multiples
Traphaco JSC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
VN
Traphaco JSC
VN:TRA
3.2T VND 1.4 15.4 6.8 8.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
843.2B USD 21.7 114.8 57.4 64.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.4T DKK 13.3 38.2 25.5 29.2
US
Johnson & Johnson
NYSE:JNJ
385.8B USD 4.5 10.1 12.4 16.1
US
Merck & Co Inc
NYSE:MRK
278.3B USD 4.5 20.3 13.7 16.8
CH
Roche Holding AG
SIX:ROG
206.1B CHF 3.5 17.9 10.1 12
UK
AstraZeneca PLC
NASDAQ:AZN
240.2B USD 4.9 37.3 17.1 25.6
CH
Novartis AG
SIX:NOVN
191.2B CHF 4.6 13.8 10.9 16.1
US
Pfizer Inc
NYSE:PFE
162B USD 2.9 -62.4 12.6 20.4
P/E Multiple
Earnings Growth
VN
T
Traphaco JSC
VN:TRA
Average P/E: 33.5
15.4
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
114.8
425%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
38.2
90%
US
Johnson & Johnson
NYSE:JNJ
10.1
-22%
US
Merck & Co Inc
NYSE:MRK
20.3
7 419%
CH
Roche Holding AG
SIX:ROG
17.9
30%
UK
A
AstraZeneca PLC
NASDAQ:AZN
37.3
175%
CH
Novartis AG
SIX:NOVN
13.8
19%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -62.4
712%

See Also

Discover More
Back to Top